Stocktoria
DSM-Firmenich AG DSFIR.AS
NL · Euronext Amsterdam · XAMS · stock · Basic Materials · website
DSM-Firmenich AG financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | €9.0B | €9.1B | €10.6B | €8.4B |
| Gross profit | €3.5B | €3.6B | €2.6B | €2.7B |
| R&D expense | €713.0M | €814.0M | €652.0M | €295.0M |
| SG&A expense | €2.2B | €2.2B | €2.5B | €1.8B |
| Operating income | €632.0M | €551.0M | -€507.0M | €657.0M |
| Interest expense | €159.0M | €165.0M | €168.0M | €130.0M |
| Income tax | €118.0M | €64.0M | -€18.0M | €124.0M |
| Net income | -€1.1B | €250.0M | €2.1B | €1.7B |
| EPS (diluted) | — | €0.84 | €9.13 | €11.24 |
| Operating cash flow | €1.4B | €1.8B | €1.3B | €965.0M |
| Free cash flow | €651.0M | €1.0B | €558.0M | €281.0M |
| Cash & equivalents | €1.8B | €2.7B | €2.5B | €2.8B |
| Inventory | €2.1B | €3.3B | €3.4B | €2.3B |
| Goodwill | €9.4B | €11.2B | €11.3B | €3.0B |
| Total assets | €29.3B | €33.7B | €34.3B | €17.4B |
| Total debt | €5.3B | €5.3B | €4.8B | €3.1B |
| Total liabilities | €10.9B | €11.1B | €11.2B | €6.6B |
| Shareholders' equity | €18.2B | €22.5B | €22.9B | €10.7B |
| Share buybacks | €1.2B | €706.0M | €256.0M | €210.0M |
Growth · year-over-year · Revenue CAGR 2.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | -0.2% | -14.8% | +26.7% | — |
| Net income growth | -532.4% | -88.3% | +25.7% | — |
| EPS growth | — | -90.8% | -18.8% | — |
| Free cash flow growth | -35.3% | +80.3% | +98.6% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · NL · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.